Circulating Extracellular Vesicles and Endothelial Damage in Sickle Cell Disease

Area of Science:

• Hematology
• Vascular Biology
• Cell Biology

Background:

• Endothelial damage is a key factor in sickle cell disease complications.
• Circulating extracellular vesicles (EVs) influence endothelial function in vascular diseases.
• Sickle cell patient plasma contains diverse EVs, including microparticles and exosomes, from various cell types.

Purpose of the Study:

• To investigate the role of circulating extracellular vesicles (EVs) in sickle cell disease pathogenesis.
• To explore the contribution of different EV sizes and sources to endothelial damage.

Main Methods:

• Analysis of circulating EVs in sickle cell disease patients.
• Characterization of EV size, cellular origin, and functional properties (e.g., procoagulant, inflammatory).
• Review of studies implicating EVs in vaso-occlusion and endothelial integrity disruption.

Main Results:

• Medium-sized EVs (microparticles) from erythrocytes and platelets can be procoagulant, inflammatory, or increase endothelial adhesiveness.
• Small EVs (exosomes) from various cells, including erythrocytes, can alter target cell behavior via delivered cargo.
• Both medium and small EVs are implicated in promoting vaso-occlusion and endothelial damage in sickle cell disease models.

Conclusions:

• Circulating EVs, both medium and small, significantly contribute to endothelial damage in sickle cell disease.
• Further understanding of EV composition and function is crucial for developing predictive diagnostics and novel therapeutics for sickle cell disease.